Pacira BioSciences, Inc. PCRX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s change in accrued liabilities?
- Pacira BioSciences, Inc. (PCRX) reported change in accrued liabilities of -$10.31M in Q1 2026.
- How has Pacira BioSciences, Inc.'s change in accrued liabilities changed year-over-year?
- Pacira BioSciences, Inc.'s change in accrued liabilities decreased by 319.2% year-over-year, from $4.7M to -$10.31M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.